Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A comparison of fine-needle aspiration, core biopsy, and surgical biopsy in the diagnosis of extremity soft tissue masses.ClinOrthopRelat Res. 2010; 468: 2992-3002
- Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies.Mod Pathol. 2017; 30: 499-508
- Relative sensitivity of core-needle biopsy and incisional biopsy in the diagnosis of musculoskeletal sarcomas.Cancers (Basel). 2021; 13: 1393
- Core needle biopsy versus incisional biopsy for differentiation of soft-tissue sarcomas: a systematic review and meta-analysis.Cancer. 2020; 126: 1917-1928
- Fine-needle aspiration followed by core-needle biopsy in the same setting: modifying our approach.ActaCytol. 2016; 60: 1-13
- Fine-needle aspiration and core needle biopsy: an update on 2 common minimally invasive tissue sampling modalities.Cancer Cytopathol. 2016; 124: 862-870
- Diagnostic efficacy and molecular testing by combined fine needle aspiration and core needle biopsy in patients with a lung nodule.Cancer Cytopathol. 2020; 128: 201-206
- Identification of factors affecting the success of next-generation sequencing testing in solid tumors.Am J ClinPathol. 2016; 145: 222-237
- Preanalytic variables in cytology: lessons learned from next-generation sequencing-the MD Anderson experience.Arch Pathol Lab Med. 2016; 140: 1191-1199
- Impact of rapid on-site cytological evaluation (ROSE) on the diagnostic yield of transbronchial needle aspiration during mediastinal lymph node sampling: systematic review and meta-analysis.Chest. 2018; 153: 929-938
- Rapid on-site evaluation for endoscopic ultrasound-guided fine-needle biopsy of the pancreas decreases the incidence of repeat biopsy procedures.Cancer Cytopathol. 2013; 121: 518-524
- Usefulness of rapid on-site evaluation specimens from endoscopic ultrasound-guided fine-needle aspiration for cancer gene panel testing: a retrospective study.PLoS One. 2020; 15: e0228565
- Utility of endoscopic ultrasound-guided fine-needle aspiration cytology in rapid on-site evaluation for the diagnosis of gastric submucosal tumors: retrospective analysis of a single-center experience.DiagnCytopathol. 2019; 47: 869-875
- Rapid on-site evaluation by endosonographers during endoscopic ultrasonography-guided fine-needle aspiration for diagnosis of gastrointestinal stromal tumors.ClinEndosc. 2017; 50: 372-378
- Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)-part 2: subjective views among the cytopathology community.J Am SocCytopathol. 2020; 9: 570-578
- Results from the 2019 American Society of Cytopathology survey on rapid on-site evaluation-Part 1: objective practice patterns.J Am SocCytopathol. 2019; 8: 333-341
- Validating whole slide imaging for diagnostic purposes in pathology: guideline from the College of American Pathologists Pathology and Laboratory Quality Center.Arch Pathol Lab Med. 2013; 137: 1710-1722
- Telecytology for rapid on-site evaluation: current status.J Am SocCytopathol. 2018; 7: 1-6
- Rapid on-site evaluation using telecytology: a major cancer center experience.DiagnCytopathol. 2019; 47: 15-19
- Robotic telecytology for remote cytologic evaluation without an on-site cytotechnologist or cytopathologist: an active quality assessment and experience of over 400 cases.J Pathol Inform. 2017; 8: 35
- Effect of fixatives and tissue processing on the content and integrity of nucleic acids.Am J Pathol. 2002; 161: 1961-1971
- A high frequency of sequence alterations is due to formalin fixation of archival specimens.Am J Pathol. 1999; 155: 1467-1471
- CytoLyt fixation significantly inhibits MIB1immunoreactivity whereas alternative Ki-67 clone 30-9 is not susceptible to the inhibition: critical diagnostic implications.Cancer Cytopathology. 2019; 127: 643-649
- CytoLyt(R) fixation and decalcification pretreatments alter antigenicity in normal tissues compared with standard formalin fixation.ApplImmunohistochemMolMorphol. 2015; 23: 297-302
- Effects of short and long-term alcohol-based fixation on Sprague-Dawley rat tissue morphology, protein and nucleic acid preservation.ActaHistochem. 2019; 121: 750-760
- Do more with less: tips and techniques for maximizing small biopsy and cytology specimens for molecular and ancillary testing: the university of Colorado experience.Arch Pathol Lab Med. 2016; 140: 1206-1220
- Do molecular profiles of primary versus metastatic radioiodine refractory differentiated thyroid cancer differ?.Front Endocrinol. 2021; 12: 623182
- Frequency of discordance in programmed death-ligand 1 (PD-L1) expression between primary tumors and paired distant metastases in advanced cancers: a systematic review and meta-analysis.ActaOncol. 2020; 59: 696-704
- Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases.ClinExpMetastasis. 2019; 36: 29-37
- Discordance in PD-L1 scores on repeat testing of non-small cell lung carcinomas.Cancer Treat Res Commun. 2021; 27: 100353
- Cell blocks in cytopathology: an update.Cytopathology. 2018; 29: 505-524
- Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics.Mod Pathol. 2014; 27: 314-327
- Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.Cancer Cytopathol. 2013; 121: 361-369
- Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.Cancer Cytopathol. 2017; 125: 30-40
- Diff-quik cytology smears from endobronchial ultrasound transbronchial needle aspiration lymph node specimens as a source of DNA for next-generation sequencing instead of cell blocks.Respiration. 2019; 97: 525-539
- Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.Cancer Cytopathol. 2021; 129: 374-382
- Molecular testing of non-small cell lung carcinoma diagnosed by endobronchial ultrasound-guided transbronchial fine-needle aspiration: the cleveland clinic experience.Arch Pathol Lab Med. 2019; 143: 670-676
- Epidermal growth factor receptor test performed on liquid-based cytology lung samples: experience of an academic referral center.ActaCytol. 2014; 58: 589-594
- Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: a worldwide ring trial study on quantitative cytological molecular reference specimens.Cancer Cytopathol. 2017; 125: 615-626
- Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling.Mod Pathol. 2018; 31: 1036-1045
- Mutational analysis of cytocentrifugation supernatant fluid from pancreatic solid mass lesions.DiagnCytopathol. 2014; 42: 719-725
- Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.Cancer Cytopathol. 2015; 123: 356-361
- Molecular diagnosis using residual liquid-based cytology materials for patients with nondiagnostic or indeterminate thyroid nodules.EndocrinolMetab(Seoul). 2016; 31: 586-591
- Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.Cancer Cytopathol. 2019; 127: 146-160
- Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.Lung Cancer. 2018; 122: 72-75
- Liquid biopsy: a family of possible diagnostic tools.Diagnostics (Basel). 2021; 11: 1391
- Cell-free nucleic acids as biomarkers in cancer patients.Nat Rev Cancer. 2011; 11: 426-437
- Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC.J ThoracOncol. 2018; 13: 1248-1268
- Liquid biopsy enters the clinic - implementation issues and future challenges.Nat Rev ClinOncol. 2021; 18: 297-312
- Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.J ExpClinCancer Res. 2020; 39: 95
- Circulating mutant DNA to assess tumor dynamics.Nat Med. 2008; 14: 985-990
- Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib.Cancer. 2014; 120: 3896-3901
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.Nature. 2012; 486: 537-540
- Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer.Expert Rev MolDiagn. 2015; 15: 1427-1440
- Absolute quantification by droplet digital PCR versus analog real-time PCR.Nat Methods. 2013; 10: 1003-1005
- Next-generation sequencing in liquid biopsy: cancer screening and early detection.Hum Genomics. 2019; 13: 34
- Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.Ann Oncol. 2017; 28: 2943-2949
- Factors affecting the success of next-generation sequencing in cytology specimens.Cancer Cytopathol. 2015; 123: 659-668
- Cytophotometric studies of the DNA, nucleic acid and protein content of human liver cell nuclei.ActaCytol. 1976; 20: 151-157
- Guidelines for validation of next-generation sequencing-based oncology panels: a Joint consensus recommendation of the association for molecular pathology and college of American pathologists.J MolDiagn. 2017; 19: 341-365
- Analysis of pre-analytic factors affecting the success of clinical next-generation sequencing of solid organ malignancies.Cancers (Basel). 2015; 7: 1699-1715
- Impact of tumor necrosis on success of clinical next generation sequencing.Mod Pathol. 2015; 28: 501a
- The current state of molecular testing in the treatment of patients with solid tumors, 2019.CACancer J Clin. 2019; 69: 305-343
- A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen?.Arch Pathol Lab Med. 2014; 138: 1520-1530
- Preanalytic specimen triage: smears, cell blocks, cytospin preparations, transport media, and cytobanking.Cancer Cytopathol. 2017; 125: 455-464
- Improving adequacy of small biopsy and fine-needle aspiration specimens for molecular testing by next-generation sequencing in patients with lung cancer: a quality improvement study at Dartmouth-Hitchcock medical center.Arch Pathol Lab Med. 2017; 141: 402-409
- EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.Am J ClinPathol. 2010; 133: 922-934
- Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.Am J ClinPathol. 2015; 143: 573-578
- Targeted therapy in advanced non-small cell lung cancer: current advances and future trends.J HematolOncol. 2021; 14: 108
- DNA-based versus RNA-based detection of MET exon 14 skipping events in lung cancer.J ThoracOncol. 2019; 14: 737-741
- Translating RNA sequencing into clinical diagnostics: opportunities and challenges.Nat Rev Genet. 2016; 17: 257-271
- RNA-based detection of gene fusions in formalin-fixed and paraffin-embedded solid cancer samples.Cancers (Basel). 2019; 11: 1309
- NanoStringnCounter technology: high-throughput RNA validation.MethodsMol Biol. 2020; 2079: 125-139
- RNA-based multiplexing assay for routine testing of fusion and splicing variants in cytological samples of NSCLC patients.Diagnostics (Basel). 2020; 11: 15
- Digital multiplexed gene expression analysis of mRNA and miRNA from routinely processed and stained cytological smears: a proof-of-principle study.ActaCytol. 2021; 65: 88-98
- ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.ActaNeuropathol. 2015; 129: 133-146
- PD-L1 testing in guiding patient selection for PD-1/PD-L1 inhibitor therapy in lung cancer.MolDiagnTher. 2018; 22: 1-10
- Fit-for-purpose PD-L1 biomarker testing for patient selection in immuno-oncology: Guidelines for clinical laboratories from the Canadian association of pathologists-Association canadienneDes pathologistes (CAP-ACP).ApplImmunohistochemMolMorphol. 2019; 27: 699-714
- PD-1 blockade in tumors with mismatch-repair deficiency.N Engl J Med. 2015; 373: 1979
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.Science. 2017; 357: 409-413
- PD-L1 expression in non-small cell lung carcinoma: comparison among cytology, small biopsy, and surgical resection specimens.Cancer Cytopathol. 2017; 125: 896-907
- Evaluating mismatch repair/microsatellite instability status using cytology effusion specimens to determine eligibility for immunotherapy.Arch Pathol Lab Med. 2020; 145: 46-54
- Programmed death-ligand 1 expression on direct Pap-stained cytology smears from non-small cell lung cancer: comparison with cell blocks and surgical resection specimens.Cancer Cytopathol. 2019; 127: 470-480
- ALK and ROS1 testing on lung cancer cytologic samples: Perspectives.Cancer Cytopathol. 2017; 125: 817-830
- Cytologic evaluation of p16 staining in head and neck squamous cell carcinoma in CytoLyt versus formalin-fixed material.Cancer Cytopathol. 2019; 127: 750-756
- Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma.Cancer. 2004; 102: 34-40
- Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer.Ann Oncol. 2018; 29: 1417-1422
- Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.Cancer Cytopathol. 2018; 126: 342-352
- Paired comparison of PD-L1 expression on cytologic and histologic specimens from malignancies in the lung assessed with PD-L1IHC 28-8pharmDx and PD-L1IHC22C3pharmDx.ApplImmunohistochemMolMorphol. 2017; 25: 453-459
- Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer.Mod Pathol. 2021; 34: 532-541
Article info
Publication history
Published online: August 22, 2022
Footnotes
Conflict of Interest: The authors have nothing to disclose.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
